IFNG and hemophagocytic syndrome: As previously discussed, experimental mouse models and ex vivo observations provide the rationale behind the use of IFN-γ inhibiting strategies for the treatment of HLH on account of the importance of the underlying IFN-γ-associated pathogenetic mechanisms of the disease [31,34,35,36,38,39,40,41].